PHARMA MAR, S.A. «12345...» Page 3 out of 23 08/07/2024 10:33 PHARMA MAR, S.A. On business and financial situation The European Commission revokes the decision by which it initially refused to allow Pharma Mar to market Aplidin for multiple myeloma because of a conflict of interest. Register number: 29559 03/07/2024 17:59 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement between 01/04/2024 and 30/06/2024 Register number: 29516 01/07/2024 17:35 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 24 June and 28 June 2024. Register number: 29467 24/06/2024 17:37 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 17 June and 21 June 2024. Register number: 29287 17/06/2024 17:45 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 10 June and 14 June 2024. Register number: 29175 10/06/2024 17:36 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 3 June and 7 June 2024. Register number: 29076 03/06/2024 17:41 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 27 May and 31 May 2024. Register number: 28979 29/05/2024 13:09 PHARMA MAR, S.A. Other relevant information The Company informs about the dividend payment Register number: 28891 29/05/2024 13:01 PHARMA MAR, S.A. Announcement of general shareholders’ meeting It is reported that all proposed resolutions submitted by the Board to the General Shareholders’ Meeting have been approved. Register number: 28890 29/05/2024 10:23 PHARMA MAR, S.A. Announcement of general shareholders’ meeting Attached is a copy of the presentation to shareholders to be made at the General Shareholders’ Meeting of Pharma Mar by the Chairman and by the Chief Financial Officer of the Company. Register number: 28883 Page 3 out of 23 «12345...»
